Cargando…
miR-132 is upregulated in polycystic ovarian syndrome and inhibits granulosa cells viability by targeting Foxa1
Polycystic ovary syndrome (PCOS) is one of the most common endocrine metabolic disorders characterized by hyperandrogenism, polycystic ovaries and ovulatory dysfunction. Several studies have suggested that the aberrant expression of microRNAs (miRNAs/miRs) plays an important role in the pathogenesis...
Autores principales: | Cui, Xiangrong, Jing, Xuan, Liu, Junfen, Bi, Xingyu, Wu, Xueqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646966/ https://www.ncbi.nlm.nih.gov/pubmed/33174054 http://dx.doi.org/10.3892/mmr.2020.11590 |
Ejemplares similares
-
miR-132 Targets FOXA1 and Exerts Tumor-Suppressing Functions in Thyroid Cancer
por: Chen, Xin, et al.
Publicado: (2019) -
Increased miR-188-3p in Ovarian Granulosa Cells of Patients with Polycystic Ovary Syndrome
por: Dai, Beibei, et al.
Publicado: (2021) -
Granulosa cell-derived miR-379-5p regulates macrophage polarization in polycystic ovarian syndrome
por: Salehi, Reza, et al.
Publicado: (2023) -
miR-206 serves an important role in polycystic ovary syndrome through modulating ovarian granulosa cell proliferation and apoptosis
por: Zhou, Jie, et al.
Publicado: (2021) -
Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer
por: Jing, Xuan, et al.
Publicado: (2019)